Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:CE 26:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004217 AN007016 Lipid Alterations in ASAH1-Deficient Cells: Insights into Ceramide Accumulation and Lysosomal Dysfunction Cultured cells Human Metabolic disease Harvard Medical School LC-MS
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST004095 AN006788 Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics Cultured cells Human Cancer Amgen LC-MS
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003760 AN006174 Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003758 AN006170 Untargeted lipidomics of gemcitabine-resistant cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003757 AN006168 Untargeted lipidomics of gemcitabine-resistant PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003717 AN006098 Lipidomics analysis of mouse pancreatic cancer cells cultured RPMI, TIFM, or TIFM + arginine under lipid deprivation Cultured cells Mouse Cancer University of Chicago LC-MS
ST003715 AN006096 Lipidomics analysis of mouse PDAC cell lines treated with tung oil Cultured cells Mouse Cancer University of Chicago LC-MS
ST003714 AN006095 Lipidomics analysis of mouse PDAC cell lines treated with alpha-eleostearic acid Cultured cells Mouse Cancer University of Chicago LC-MS
ST003629 AN005962 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST003341 AN005475 Untargeted Lipidomic Profiling of Canine Cancer Cell Lines Cultured cells Dog Cancer Kojin Therapeutics, Inc. LC-MS
ST003328 AN005453 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Stem cells Human Multiple sclerosis University of Colorado Denver LC-MS
ST003242 AN005311 Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. Kidney Mouse Oxidative stress University of Rochester Medical Center LC-MS
ST003242 AN005311 Lipidomic analysis of kidney from Gclc WT and whole-body Gclc KO mice. Kidney Mouse Stress University of Rochester Medical Center LC-MS
ST003125 AN005123 Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Fetal liver Liver Mouse Maternal immune system activation University of Copenhagen LC-MS
ST002713 AN004398 Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics Cultured cells Human Cancer University of Colorado Denver LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002452 AN004007 Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations Brain Human Dementia University of Sydney LC-MS
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky LC-MS
ST000114 AN000192 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo